Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021089543> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2021089543 endingPage "A455" @default.
- W2021089543 startingPage "A455" @default.
- W2021089543 abstract "To compare prices of new drugs between France and the other EU4. Study used IMS MIDAS database for economic data such as prices and sales volume and LEEM database (French association of the pharmaceutical manufacturers) for the ASMR scale (HAS assessment of the drug’s added value/innovation). All the products applying for the first time for reimbursement by the French Public health insurance between January 2008 and June 2012 were included in the study (except those restricted to hospital use in France) and having an ASMR rating and an official price in June 2012. Paasche and Laspeyres price-index were calculated for drugs with: a) high ASMR, b) ASMR IV, c) ASMR V and d) all drugs. A sensitivity analysis was conducted to measure the effect of different weighting options. A total of 107 products (245 dosages) were included in this study. Fifty-one (48%) have been found available in the community pharmacies of all the 5 countries. The availability analysis by pair of countries (France + another) is higher: 94 for Germany, 79 for UK, 71 for Spain and 69 for Italy (Italy often restricts drug’s access to hospitals only). French prices are generally equal to or lower than prices in the four other markets, which shows a relative price index decrease for France since 2008 studies. The only significant exception are UK prices for products ranked in France ASMR 1-2-3 (20% less expensive). Prices are regularly and significantly higher in Germany than in all other countries. Interestingly, the highest disparities in prices occur for the ones ranked as most innovative in France – while ASMR IV have surprisingly consistent prices across EU5. European patients don’t have consistent access to the same drugs in retail market, and the drugs considered innovative in France show a large price index disparity across EU5, with UK prices being 20% lower." @default.
- W2021089543 created "2016-06-24" @default.
- W2021089543 creator A5050671660 @default.
- W2021089543 creator A5057498052 @default.
- W2021089543 creator A5068512939 @default.
- W2021089543 date "2013-11-01" @default.
- W2021089543 modified "2023-10-01" @default.
- W2021089543 title "A Price Comparison Study of Recent Drugs in EU5, 2008-2012" @default.
- W2021089543 doi "https://doi.org/10.1016/j.jval.2013.08.762" @default.
- W2021089543 hasPublicationYear "2013" @default.
- W2021089543 type Work @default.
- W2021089543 sameAs 2021089543 @default.
- W2021089543 citedByCount "0" @default.
- W2021089543 crossrefType "journal-article" @default.
- W2021089543 hasAuthorship W2021089543A5050671660 @default.
- W2021089543 hasAuthorship W2021089543A5057498052 @default.
- W2021089543 hasAuthorship W2021089543A5068512939 @default.
- W2021089543 hasBestOaLocation W20210895431 @default.
- W2021089543 hasConcept C10138342 @default.
- W2021089543 hasConcept C104863432 @default.
- W2021089543 hasConcept C105795698 @default.
- W2021089543 hasConcept C136764020 @default.
- W2021089543 hasConcept C144133560 @default.
- W2021089543 hasConcept C149782125 @default.
- W2021089543 hasConcept C160735492 @default.
- W2021089543 hasConcept C162324750 @default.
- W2021089543 hasConcept C178131030 @default.
- W2021089543 hasConcept C182306322 @default.
- W2021089543 hasConcept C2776291640 @default.
- W2021089543 hasConcept C2777382242 @default.
- W2021089543 hasConcept C2779703844 @default.
- W2021089543 hasConcept C33923547 @default.
- W2021089543 hasConcept C41008148 @default.
- W2021089543 hasConcept C48824518 @default.
- W2021089543 hasConcept C50522688 @default.
- W2021089543 hasConcept C512399662 @default.
- W2021089543 hasConcept C71924100 @default.
- W2021089543 hasConceptScore W2021089543C10138342 @default.
- W2021089543 hasConceptScore W2021089543C104863432 @default.
- W2021089543 hasConceptScore W2021089543C105795698 @default.
- W2021089543 hasConceptScore W2021089543C136764020 @default.
- W2021089543 hasConceptScore W2021089543C144133560 @default.
- W2021089543 hasConceptScore W2021089543C149782125 @default.
- W2021089543 hasConceptScore W2021089543C160735492 @default.
- W2021089543 hasConceptScore W2021089543C162324750 @default.
- W2021089543 hasConceptScore W2021089543C178131030 @default.
- W2021089543 hasConceptScore W2021089543C182306322 @default.
- W2021089543 hasConceptScore W2021089543C2776291640 @default.
- W2021089543 hasConceptScore W2021089543C2777382242 @default.
- W2021089543 hasConceptScore W2021089543C2779703844 @default.
- W2021089543 hasConceptScore W2021089543C33923547 @default.
- W2021089543 hasConceptScore W2021089543C41008148 @default.
- W2021089543 hasConceptScore W2021089543C48824518 @default.
- W2021089543 hasConceptScore W2021089543C50522688 @default.
- W2021089543 hasConceptScore W2021089543C512399662 @default.
- W2021089543 hasConceptScore W2021089543C71924100 @default.
- W2021089543 hasIssue "7" @default.
- W2021089543 hasLocation W20210895431 @default.
- W2021089543 hasLocation W20210895432 @default.
- W2021089543 hasOpenAccess W2021089543 @default.
- W2021089543 hasPrimaryLocation W20210895431 @default.
- W2021089543 hasRelatedWork W1436160343 @default.
- W2021089543 hasRelatedWork W1981749217 @default.
- W2021089543 hasRelatedWork W2006811417 @default.
- W2021089543 hasRelatedWork W2030121831 @default.
- W2021089543 hasRelatedWork W2055130606 @default.
- W2021089543 hasRelatedWork W2093961132 @default.
- W2021089543 hasRelatedWork W2139035496 @default.
- W2021089543 hasRelatedWork W2563532211 @default.
- W2021089543 hasRelatedWork W2620039785 @default.
- W2021089543 hasRelatedWork W3122489185 @default.
- W2021089543 hasVolume "16" @default.
- W2021089543 isParatext "false" @default.
- W2021089543 isRetracted "false" @default.
- W2021089543 magId "2021089543" @default.
- W2021089543 workType "article" @default.